Chatham Rock Closes Private Placement of Shares
NEWS RELEASE 24- 28 September 10, 2024
CHATHAM ROCK CLOSES PRIVATE PLACEMENT OF SHARES
WELLINGTON New Zealand – Chatham Rock Phosphate Limited (TSXV: “NZP”, NZX: “CRP”
and “3GRE” (Frankfurt) or the “Company”) is pleased to report that it has closed a private placement
of shares (the “Offering”) by issuing a total of 1,405,555 common shares (the “Shares”) at a price of
CA$0.08 (NZ$0.10 and AU$0.09) per Share, raising gross proceeds of CA$112,440.40
(NZ$140,555.50 or AU$126,499.95).
All securities issued are subject to a hold period until January 11, 2025.
Use of Funds
The funds raised will be used for the following purposes:
• Fast tracking the mine development at Korella North in Queensland;
• Continuation of the permitting process for the Avenir Makatea onshore phosphate project in
French Polynesia; and
• General working capital.
The subscription to the Offering by one insider of the Issuer is a related party transaction for the
purposes of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special
Transactions (“MI 61-101”), but the Issuer is relying on exemptions from the formal valuation and
minority shareholder approval requirements provided under sections 5.5(a) and 5.7(1)(a) of MI 61-101
on the basis that the fair market value of the subscription, insofar as it involves the insider of the Issuer,
does not exceed 25% of the market capitalization of the Issuer, as determined in accordance with MI
61-101.
For further information please contact:
Chris Castle
President and Chief Executive Officer
Chatham Rock Phosphate Limited
64 21 55 81 85 or chris@crpl.co.nz
Statements about the Company’s future expectations and all other statements in this press release other than historical
facts are “forward looking statements”. Such forward-looking statements are based on numerous assumptions, and
involve known and unknown risks, uncertainties and other factors, including risks inherent in mineral exploration and
development, which may cause the actual results, performance, or achievements of the Company to be materially
different from any projected future results, performance, or achievements expressed or implied by such forward-looking
statements.
Neither the Exchange, its Regulation Service Provider (as that term is defined under the policies of the Exchange), or
New Zealand Exchange Limited has in any way passed upon the merits of the above descried transaction, and has
neither approved nor disapproved of the contents of this press release.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- PHL — Promisia Healthcare Limited: Amended Corporate Action Notice and update on placements2024-07-03
“2 of 3 Closing date 5pm, 29 July 2024 Allotment date 5 August 2024 Section 7: Placement (delete full section if not applicable, or mark rows as N/A if not applicable)* Number of Equity Securities to be issued Up to 3,227,446,274 shares (with a maximum of 4,000,000,000 sh…”